Equal Footing: ETFS Magnificent 7+ ETF (ASX:HUGE) Weights the Nasdaq's Biggest Names Alike

Sonal Goyal

28 October 2026 12:31 PM AEDT

Equal Footing: ETFS Magnificent 7+ ETF (ASX:HUGE) Weights the Nasdaq's Biggest Names Alike

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

ETFS Magnificent 7+ ETF (ASX:HUGE) aims to provide access to the 10 largest Nasdaq-listed, US-domiciled companies on an equal-weighted basis.
The fund holds 11 holdings, with Advanced Micro Devices, Inc. the largest position at 11.83%.
The fund has a management fee of 0.19% and a fund size of $29.23 million.

As of 27 October, ETFS Magnificent 7+ ETF (ASX:HUGE) manages $29.23 million across 11 holdings, weighting the largest Nasdaq-listed US companies on an equal basis. It was admitted on 19 November 2025 and charges 0.19%.

Key Fact	Detail
Fund	ETFS Magnificent 7+ ETF
ASX code	HUGE
Issuer	ETFS (etfshares.com.au)
Category	Equity North America
Benchmark	Solactive Magnificent 7+ NR USD
ISIN	AU0000393373
Admitted to the ASX	19 November 2025
Fund size	$29.23 million
Management fee	0.19%
Holdings	11 holdings
Latest distribution	Final, $0.236 per unit (ex-date 30 Jun 2026; payment 17 Jul 2026)

Equal Weighting in Practice

With equal weighting, no single company is meant to dominate. The positions range from 7.96% to 11.83%: Advanced Micro Devices (11.83%), Meta Platforms (11.78%), Micron Technology (11.19%), Tesla (10.30%), Apple (9.94%), Microsoft (9.80%), NVIDIA (9.72%), Alphabet (8.83%), Amazon (8.49%) and Broadcom (7.96%).

Sector Mix and Fund Details

Technology is 60.55% of the portfolio, communication services 20.64% and consumer cyclical 18.82%. All holdings are in the United States and above $1 billion in market capitalisation. The fund is categorised as Equity North America and benchmarked to the Solactive Magnificent 7+ NR USD index.

Additional Allocation Data

Size breakdown: 100% of the portfolio is in companies above $1 billion in market capitalisation. Country exposure is split across United States (100.00%).

Latest Payment Details

Under the latest distribution announcement, $0.236 per unit (final) is payable on 17 July 2026 to holders on the record date of 1 July 2026, following an ex-date of 30 June 2026.

Regulatory Notices

Notices lodged recently include an annual report on 29 September 2026, a notice of change of auditor on 17 August 2026 and monthly units on issue and fund flows reports.

Understanding the Category

ETFS Magnificent 7+ ETF is classified as Equity North America. Funds in this category invest in the securities of companies listed in the USA and/or Canada, and securities from these countries typically account for at least 75% of the portfolio.

Benchmark Background

The Solactive Magnificent 7+ NR USD index is the fund's benchmark. The fund is relatively new, having been admitted to the ASX on 19 November 2025. ETFS (etfshares.com.au) is the issuer, and the ISIN is AU0000393373. The fee is 0.19%.

Weight of the Largest Positions

The top five holdings add up to 55.04% of the portfolio, with Advanced Micro Devices, Inc. the largest at 11.83%.

Distribution Dates Explained

Distributions follow a set sequence. Units go ex-distribution first, the record date then fixes who is entitled, and payment follows on the payment date.

In Summary

HUGE offers equal-weighted exposure to a small group of very large US companies at a low 0.19% fee. The latest distribution was a final payment of $0.236 per unit on 17 July 2026.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.